RPRX — Royalty Pharma plc
In 2026 Q2, 4 of the 140 tracked hedge funds reported a position in Royalty Pharma plc (RPRX), worth $115.08M combined. Over the quarter 3 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $108.54M | 0.15% | +144.7% |
| VanEck | $5.68M | 0.00% | -27.2% |
| Polymer | $535.58K | 0.08% | NEW |
| Persistent | $325.04K | 0.10% | +12% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.